JAGSONPAL PHARMACEUTICALS
|
The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 5.86.
Share Price | ₹237.0 | May 30,2025 |
Market Cap | ₹1,575.7 Cr | |
Sales-TTM | ₹268.7 Cr | TTM-Standalone Results |
Price/Sales | 5.86x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,575.7 Cr] as on May 30,2025
(/) Sales [ ₹268.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.86x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '5.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS
PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.39x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 3.78x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.29x.
How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
JAGSONPAL PHARMACEUTICALS | 268.7 | 5.86 | 1,575.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.66 | 402,680.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.75 | 175,532.0 |
CIPLA LTD | 27,547.6 | 4.29 | 118,315.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.33 | 107,421.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.20 | 104,453.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.31 | 102,080.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.03 | 93,564.7 |
LUPIN LTD | 22,707.9 | 3.94 | 89,439.2 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.10 | 66,647.0 |
ABBOTT INDIA LTD | 6,409.2 | 10.10 | 64,710.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.10x |
Max industry PS | 18.75x |
Median industry PS | 5.86x |
Average industry PS | 7.05x |
You may also like the below Video Courses